News Archive

Date: 01/20/2012
University of Michigan Health System is first U.S. academic site to put GE's Veo, which greatly reduces the amount of radiation exposure and therefore, cancer risk, into clinical use.
Date: 01/17/2012
Pavan Reddy, M.D., associate professor of hematology/oncology at the U-M Medical School, was the senior researcher who discovered alpha-1-antitrypsin -- a natural enzyme -- reduces intense inflammation after bone marrow transplant.
Date: 01/16/2012
Researchers at the University of Michigan have found that matted lymph nodes appear to signal increased chance of oropharyngeal cancer spreading to other parts of the body.
Date: 01/13/2012
In a new study, a program known as Spatially Invariant Vector Quantization (SIVQ) separated a malignancy from background tissue in digital slides of a type of bladder cancer whose features can vary widely and presents diagnostic challenges even for experts.
Date: 01/12/2012
Kathleen A. Cooney, M.D. of the University of Michigan Comprehensive Cancer Center, led this research effort which may may provide clues on prostate cancer development and who may need earlier screening.
Date: 01/12/2012
University of Michigan Health System offers free Pap test screening on January 21, 2012.
Date: 01/11/2012
Cancer Center clinics and infusion will reopen Thursday, Jan. 12, as well as all phlebotomy and radiology services on Level B2.
Date: 01/10/2012
Some Cancer Center care will be temporarily relocated or rescheduled; all other patient care continues normally.
Date: 08/04/2011
A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.
Date: 04/28/2011
Researchers at the University of Michigan Comprehensive Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease.